Wren Healthcare’s Post

Transformative news from #Blincyto! The integration of Blinatumomab in chemotherapy protocols has substantially increased survival rates for pediatric B-ALL patients. #AMGN is pioneering a new wave of treatment and hope. Discover more about this breakthrough. Click to learn more! 👉 https://bit.ly/4f19HaY

Stay in the Know: How a Stark law Interpretation Could be Harming Independent Physicians A 2021 interpretation of Stark law prohibits medication delivery from independent physician practices, which is in turn affecting patient care, according to a report in JCO Oncology Practice written by three oncologists. Read full article: https://lnkd.in/eR3R8sxV #Stayintheknowwithfusionanesthesia #stayintheknow #Fusionanesthesia #BeckersASC #starklaw #AnesthesiaInsights #HealthcareLaw #IndependentPhysicians #PatientCare #OncologyReport #StarkLawUpdate #HealthcarePolicy #MedicalRegulations

⏳ Time for change in oncology care! With skyrocketing costs and variations in treatment quality, health plans and risk-bearing groups are exploring value-based care (VBC) arrangements. However, implementing VBC can be challenging. That's why Thyme Care is here to support you. We are committed to helping organizations achieve specialty VBC success through our end-to-end oncology solution. Explore how our model fosters improved outcomes, elevates member experience, and ensures financial stability: https://lnkd.in/eSW8kZQi

On this Palliative Care and Treatment National Day of Awareness, IS-PEC highlights the role of #ImplementationScience in fostering compassionate, evidence-based healthcare that enhances patient quality of life. Palliative care isn’t just about managing end-of-life, it’s about delivering holistic, patient-centered care across the continuum of serious illness. Our mission at IS-PEC is to bridge the gap between evidence and practice, and palliative care helps ensures that patients receive care that aligns with their values and needs. A current study by IS-PEC leverages the Theoretical Domains Framework (#TDF) to identify behavioral and systemic barriers to end-of-life care in oncology. The study explored why oncologists may continue aggressive treatments at end-of-life, despite best-practice guidelines. Findings included key barriers to implementation, facilitators for change and recommendations to transforming end-of-life care. Implementation science offers a roadmap for translating research into action. By identifying what works, for whom, and in what contexts, IS-PEC is driving sustainable change to reduce overtreatment, improve care quality, and enhance patient and provider well-being. On this important day, let’s reaffirm our commitment to compassionate, evidence-based healthcare. Together, we can transform how end-of-life care is delivered, making it more personalized, effective, and aligned with patient values. #PalliativeCareandTreatmentNationalDayofAwareness #PalliativeCare #EndOfLifeCare #ImplementationScience #Oncology Saritte Perlman Aviad Raz Raphael Catane Tamar Freud Moriah Ellen

Individualised or contextualised care are buzz words, but learn how to practically consider this in your oncology patients in primary care practice! This course is not a replacement for the in depth certificate courses, but will help your rationale your reasoning and finding out what is important clinically and to the owners! Pre-register your interest now via https://bit.ly/4fM9dpO

Oncology practices can now be reimbursed for the work they do to address the #SDoH needs of patients. Read our latest blog to understand what you need to know about this historic shift and the opportunity for your practice. https://lnkd.in/eMQbMDGR #cancercare #socialdeterminantsofhealth #connectinglifetocare

There's new data out on CMS's Oncology Care Model (OCM) evaluation. Here's what you need to know: 1. Impact of two-sided risk: Practices that engaged in two-sided risk achieved net Medicare savings of $299.6 million. These practices not only excelled financially but also met the highest quality thresholds. 2. Quality vs. cost efficiency: While OCM successfully reduced costs, it fell short of improving overall care quality. The model primarily succeeded in lowering payments for higher-risk cancer types by promoting the use of more cost-effective supportive care drugs. 3. Future directions: The findings emphasize the potential for future models, such as the Enhancing Oncology Model (EOM) to build on OCM's lessons and improve qualtiy and cost efficiency in oncology care. At Innovista Health, we're committed to helping you keep tabs on all the ways value-based care transformation is going right — and how we can work together to make it even better. Check out the new data here: https://lnkd.in/e6dN7GFK

A new analysis of the Centers for Medicare & Medicaid Services’ Oncology Care Model offers insights and lessons learned for health practices caring for patients undergoing chemotherapy. Key lessons: 1️⃣ Practices can achieve rapid & sustained success in episode-based payment models, even without substantial reductions in the use of hospital-based care. 2️⃣ Episode-based oncology models hold promise for Medicare net savings. 3️⃣ Measurable changes in acute care use, like EDs and inpatient admissions, remain elusive. 4️⃣ Chemotherapy drugs remain high-cost drivers, although practices that took on two-sided risk were able to reduce Part D drug payments. Get more insights: https://lnkd.in/gZmybndw

I am excited to share an important blog post that delves into the complex realities of healthcare and accountability in the face of systemic challenges. The article, "Eat What You Kill," explores the experiences of patients and healthcare providers at St. Peter's Hospital in Montana, shedding light on the pressing issues within the oncology department. This thought-provoking piece invites readers to reflect on the implications of a profit-driven healthcare model and its impact on patient care. I encourage you to read the full article to gain insight into this critical conversation about healthcare practices and patient experiences. You can find it here: https://ift.tt/r2l9vIH.

The importance of patient insights in developing better clinical trials. Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. #patientsinsights #patientvoice #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech